5Johnston K M, Marra C A, Connors J M, et al. Cost-effec- tiveness of the addition of rituximab to chop chemothera- py in first-line treatment for diffuse large B-cell lym- phoma in a population-based observational cohort in British Columbia,Canada [J].Value Heahh,2010,13(6): 703-711.
6Deconinck E,Miadi Fargier H, Pen C L, et al. Cost effec- tiveness of rituximab maintenance therapy in follicular lymphoma: Longtermeconomie evaluation [J]. Pharma- coeeonomics, 2010,28(1):35-46.